Economic Benefit of Tuberculosis Control

Vista sencilla de ítem
dc.creatorLaxminarayan, Ramanan
dc.creatorKlein, Eili
dc.creatorDye, Christopher
dc.creatorFloyd, Katherine
dc.creatorDarley, Sarah
dc.creatorAdeyi, Olusoji
dc.date2012-06-07T22:12:03Z
dc.date2012-06-07T22:12:03Z
dc.date2007-08
dc.date.accessioned2026-07-01T01:14:04Z
dc.descriptionTuberculosis is the most important infectious cause of adult deaths after HIV/AIDS in low- and middle-income countries. This paper evaluates the economic benefits of extending the World Health Organization's DOTS Strategy (a multi-component approach that includes directly observed treatment, short course chemotherapy and several other components) as proposed in the Global Plan to Stop TB, 2006-2015. The authors use a model-based approach that combines epidemiological projections of averted mortality and economic benefits measured using value of statistical life for the Sub-Saharan Africa region and the 22 high-burden, tuberculosis-endemic countries in the world. The analysis finds that the economic benefits between 2006 and 2015 of sustaining DOTS at current levels relative to having no DOTS coverage are significantly greater than the costs in the 22 high-burden, tuberculosis-endemic countries and the Africa region. The marginal benefits of implementing the Global Plan to Stop TB relative to a no-DOTS scenario exceed the marginal costs by a factor of 15 in the 22 high-burden endemic countries, a factor of 9 (95% CI, 8-9) in the Africa region, and a factor of 9 (95% CI, 9-10) in the nine high-burden African countries. Uncertainty analysis shows that benefit-cost ratios of the Global Plan strategy relative to sustained DOTS were unambiguously greater than one in all nine high-burden countries in Africa and in Afghanistan, Pakistan, and Russia. Although HIV curtails the effect of the tuberculosis programs by lowering the life expectancy of those receiving treatment, the benefits of the Global Plan are greatest in African countries with high levels of HIV.
dc.formatapplication/pdf
dc.formattext/plain
dc.identifierhttp://documents.worldbank.org/curated/en/2007/08/8011024/economic-benefit-tuberculosis-control
dc.identifierhttps://hdl.handle.net/10986/7483
dc.identifierhttps://doi.org/10.1596/1813-9450-4295
dc.identifier.urihttp://hdl.handle.net/123456789/416342
dc.languageEnglish
dc.publisherWorld Bank, Washington, DC
dc.relationPolicy Research Working Paper; No. 4295
dc.rightsCC BY 3.0 IGO
dc.rightshttp://creativecommons.org/licenses/by/3.0/igo/
dc.rightsWorld Bank
dc.subjectADULT MORTALITY
dc.subjectAGED
dc.subjectAGRICULTURAL DEVELOPMENT
dc.subjectAGRICULTURAL PRODUCTION
dc.subjectAIDS EPIDEMIC
dc.subjectBASIC EDUCATION
dc.subjectBLUEPRINT
dc.subjectBURDEN OF DISEASE
dc.subjectCAUSES OF DEATH
dc.subjectCHEMOTHERAPY
dc.subjectCHILD DEVELOPMENT
dc.subjectCHRONIC DISEASE
dc.subjectCOMPLICATIONS
dc.subjectCOUNSELING
dc.subjectCULTURAL CHANGE
dc.subjectDEATH RATE
dc.subjectDEATH RATES
dc.subjectDEMOGRAPHIC TRANSITION
dc.subjectDEVELOPING COUNTRIES
dc.subjectDIAGNOSTICS
dc.subjectDIET
dc.subjectDISABILITY
dc.subjectDISEASE
dc.subjectDISEASE BURDEN
dc.subjectDISEASE CONTROL
dc.subjectDISEASE OF POVERTY
dc.subjectDISEASE TRANSMISSION
dc.subjectDRUG RESISTANCE
dc.subjectDRUGS
dc.subjectECONOMIC GROWTH
dc.subjectECONOMIC PROSPERITY
dc.subjectENDEMIC COUNTRIES
dc.subjectENVIRONMENTAL PROTECTION
dc.subjectEPIDEMIC
dc.subjectEPIDEMICS
dc.subjectEPIDEMIOLOGISTS
dc.subjectEPIDEMIOLOGY
dc.subjectEQUILIBRIUM
dc.subjectEXISTING POPULATION
dc.subjectEXPENDITURES
dc.subjectFAMILIES
dc.subjectFAMILY MEMBERS
dc.subjectFERTILITY
dc.subjectFORECASTS
dc.subjectFUTURE GENERATIONS
dc.subjectGLOBAL HEALTH
dc.subjectHEALTH ECONOMICS
dc.subjectHEALTH INTERVENTIONS
dc.subjectHEALTH POLICY
dc.subjectHEALTH SECTOR
dc.subjectHEALTH SERVICES
dc.subjectHEALTH STATUS
dc.subjectHEALTH SYSTEMS
dc.subjectHIV
dc.subjectHIV TESTING
dc.subjectHOUSEHOLD INCOME
dc.subjectHUMAN CAPITAL
dc.subjectHUMAN DEVELOPMENT
dc.subjectHUMAN POPULATION
dc.subjectILLNESS
dc.subjectIMMUNODEFICIENCY
dc.subjectINFECTION
dc.subjectINFECTIONS
dc.subjectINFECTIOUS DISEASES
dc.subjectINTERNATIONAL JOURNAL OF EPIDEMIOLOGY
dc.subjectINTERVENTION
dc.subjectINVESTMENT IN CHILDREN
dc.subjectIRON
dc.subjectJOURNAL OF MEDICINE
dc.subjectLABOR MARKET
dc.subjectLABOR SUPPLY
dc.subjectLIFE EXPECTANCY
dc.subjectLIVING CONDITIONS
dc.subjectLIVING STANDARDS
dc.subjectLONGER LIFE
dc.subjectLONGEVITY
dc.subjectLOW-INCOME COUNTRIES
dc.subjectLOW-INCOME COUNTRY
dc.subjectLUNG DISEASE
dc.subjectM. BOVIS
dc.subjectMALARIA
dc.subjectMALNUTRITION
dc.subjectMARKETING
dc.subjectMEDICAL RESEARCH
dc.subjectMEDICINE
dc.subjectMIGRATION
dc.subjectMILLENNIUM DEVELOPMENT GOALS
dc.subjectMINISTRY OF HEALTH
dc.subjectMORBIDITY
dc.subjectMORBIDITY AND MORTALITY
dc.subjectMORTALITY
dc.subjectMORTALITY DECLINE
dc.subjectMORTALITY DECLINES
dc.subjectMORTALITY RATE
dc.subjectMORTALITY REDUCTIONS
dc.subjectMORTALITY RISK
dc.subjectNUMBER OF DEATHS
dc.subjectNUTRITION
dc.subjectPACIFIC REGION
dc.subjectPATIENTS
dc.subjectPOLICY RESEARCH
dc.subjectPOLICY RESEARCH WORKING PAPER
dc.subjectPOOR HEALTH
dc.subjectPREMATURE DEATH
dc.subjectPREVALENCE
dc.subjectPROBABILITY
dc.subjectPROGRESS
dc.subjectPUBLIC HEALTH
dc.subjectPUBLIC HEALTH PROGRAMS
dc.subjectQUALITY OF HEALTH
dc.subjectQUALITY OF LIFE
dc.subjectREMITTANCES
dc.subjectRESOURCE CONSTRAINTS
dc.subjectRESPECT
dc.subjectRISK FACTORS
dc.subjectRISK OF DEATH
dc.subjectRISK OF INFECTION
dc.subjectRISK-TAKING BEHAVIOR
dc.subjectRISKY BEHAVIOR
dc.subjectSCHOOL CHILDREN
dc.subjectSECONDARY SCHOOL
dc.subjectSEX
dc.subjectSOCIAL MOBILIZATION
dc.subjectSUB-SAHARAN AFRICA
dc.subjectSYNDROME
dc.subjectTB
dc.subjectTB CONTROL
dc.subjectTOBACCO
dc.subjectTRANSMISSION OF INFECTION
dc.subjectTRANSMISSION RATES
dc.subjectTREATMENT
dc.subjectTUBERCULOSIS
dc.subjectTUBERCULOSIS CONTROL
dc.subjectUNEMPLOYMENT
dc.subjectUNPROTECTED SEX
dc.subjectVACCINE
dc.subjectVACCINES
dc.subjectWESTERN EUROPE
dc.subjectWORKERS
dc.subjectWORLD HEALTH ORGANIZATION
dc.subjectYOUNG ADULTS
dc.titleEconomic Benefit of Tuberculosis Control

Archivos

Colecciones

AgroKnow